Vaccines and Disease-Modifying Antirheumatic Drugs Practical Implications for the Rheumatologist

被引：45
|
作者：
Friedman, Marcia A. [1 ]
Winthrop, Kevin L. [2 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Rheumatol, Mail Code OP09,3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Infect Dis, 840 SW Gaines Rd, Portland, OR 97239 USA
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2017年 / 43卷 / 01期
关键词：
Vaccine; Rheumatoid arthritis; DMARD; Biologic; Anti-TNF; Rituximab; Immunogenicity; Efficacy; NECROSIS-FACTOR-ALPHA; B-VIRUS REACTIVATION; PNEUMOCOCCAL POLYSACCHARIDE VACCINATION; ADVISORY-COMMITTEE; ANTIBODY-RESPONSE; HERPES-ZOSTER; IMMUNIZATION PRACTICES; IMMUNE-RESPONSE; ARTHRITIS PATIENTS; INFLUENZA VACCINE;
D O I：
10.1016/j.rdc.2016.09.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with rheumatoid arthritis are highly vulnerable to infections because of abnormalities in their immune system, and because of immunosuppressive effects of their medications. Vaccinations in this population are complicated by disease-modifying antirheumatic drugs, which also modulate or suppress the immune system and potentially decrease the immunogenicity and efficacy of the vaccines. We review the available data regarding the impact of rheumatoid arthritis therapy on the immunogenicity of various common vaccines. We also review rheumatoid arthritis specific vaccination recommendations, live vaccine safety concerns, and current gaps in our understanding of these issues."
引用
收藏
页码：1 / +
页数：14
相关论文
共 50 条
  • [41] Perioperative management of disease-modifying antirheumatic drugs and other immunomodulators
    Moreira, P. M.
    Correia, A. M.
    Cerqueira, M.
    Gil, M. F.
    ARP RHEUMATOLOGY, 2022, 1 (03): : 218 - 224
  • [42] Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis
    Lin, ATH
    Clements, PJ
    Furst, DE
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (02) : 409 - +
  • [43] Disease-Modifying Antirheumatic Drugs (DMARDs) and drug interactions in dentistry
    Munoz-Martinez, C.
    Segura-Puertas, M.
    Gomez-Moreno, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2834 - 2842
  • [44] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS - POTENTIAL EFFECTS IN OLDER PATIENTS
    GARDNER, G
    FURST, DE
    DRUGS & AGING, 1995, 7 (06) : 420 - 437
  • [45] Perioperative management of disease-modifying antirheumatic drugs and other immunomodulators
    Pinho, A. M.
    Duarte, C.
    Ferreira, R. J. O.
    ARP RHEUMATOLOGY, 2023, 2 (02): : 177 - 178
  • [46] The Relationship Between Autoimmune Disease and Disease-Modifying Antirheumatic Drugs on Wound Healing
    Kirloskar, Kunal M.
    Dekker, Paige K.
    Kiene, Julianne
    Zhou, Suzanne
    Bekeny, Jenna C.
    Rogers, Ashley
    Zolper, Elizabeth G.
    Fan, Kenneth L.
    Evans, Karen K.
    Benedict, Carol Deane
    Pasieka, Helena B.
    Attinger, Christopher E.
    ADVANCES IN WOUND CARE, 2022, 11 (12) : 650 - 656
  • [47] Previous Use of Conventional Disease-Modifying Antirheumatic Drugs and Response to Baricitinib
    Kavanaugh, Arthur F.
    van Vollenhoven, Ronald F.
    Muram, David
    Alam, Jahangir
    Arora, Vipin
    Correia, Ana Luisa de Macedo Pinto
    de la Torre, Inmaculada
    O'Dell, James R.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs
    Sizova, Lyudmila
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 173 - 178
  • [49] A multidisciplinary approach for the assessment of drug interactions with disease-modifying antirheumatic drugs
    Van Roon, EN
    Wu, M
    Idzinga, F
    Van den Bernt, PMLA
    Jansen, TLTH
    Houtman, NM
    Van de Laar, MAFJ
    Wilffert, B
    Brouwers, JRBJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 462 - 462
  • [50] THE EARLY USE OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS
    MONGAN, ES
    ARTHRITIS AND RHEUMATISM, 1990, 33 (03): : 451 - 451
12345